drugset / Trial / NCT02170311
Pharmacokinetics, Pharmacodynamics and Safety Study of Z-213 to Iron Deficiency Anemia
RandomizedSingle-groupOpen-labelTreatment
Summary
The safety, tolerability, pharmacokinetics and pharmacodynamics of Z-213 will be investigated in patients with iron-deficiency anemia after administration of a single dose (100 mg, 500 mg, 800 mg or 1,000 mg iron).
Timeline
- Start
- 2014-06
- Primary completion
- 2015-02
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Z-213 | Unknown | 100 mg | Intravenous |
| Subject | Z-213 | Unknown | 500 mg | Intravenous |
| Subject | Z-213 | Unknown | 800 mg | Intravenous |
| Subject | Z-213 | Unknown | 1000 mg | Intravenous |